MedTrace Logo

Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease

NCT01828528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2016-11-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of weight loss rate on liver steatosis, steatohepatitis, fibrosis and cardiovascular risk at different stages before and after bariatric surgery. The investigators also aim to study the short-term effect of bariatric surgery on gastric cholecystokinin levels before and 10 days after the bariatric surgery.

Conditions

Interventions

PROCEDURE

Sleeve gastrectomy

An intra-operative liver biopsy was performed in 20 patients

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Ziv Ben-Ari, Prof · Director Liver Disease Center, Sheba Medical Center, Tel-Hashomer, Israel

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828528 on ClinicalTrials.gov